SEC Comment Letter for GENETHERA INC (CIK 0001017110) — Sep 25, 2020
GENETHERA INC (CIK 0001017110)
Date: Sept. 25, 2020 · CIK: 0001017110 · Accession: 0000000000-20-009057
AI Filing Summary & Sentiment
File numbers found in text: 000-27237
Letter
United States securities and exchange commission logo September 25, 2020 Antonio Milici Chief Executive Officer GeneThera, Inc. 3051 W 105th Ave. #350251 Westminster, CO 80035 Re:GeneThera, Inc. Form 10-K for the Fiscal Year Ended December 31, 2019 Filed June 10, 2020 File No. 000-27237 Dear Mr. Milici: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
September 25, 2020
Antonio Milici
Chief Executive Officer
GeneThera, Inc.
3051 W 105th Ave. #350251
Westminster, CO 80035
Re:GeneThera, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2019
Filed June 10, 2020
File No. 000-27237
Dear Mr. Milici:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences